REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/11/2025
Voltar para busca
Dado oficial do USPTO
DENK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
04/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35
Data de depósito
06/02/2019
Data de registro
03/11/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/11/2020
Última transação
04/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
28
Localização do titular
DE
Examinador
SEVERSON,JUSTIN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DENK PHARMA GmbH & Co. KG
Representantes
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and chemical preparations for medical purposes for the treatment of diseases and/or conditions of alimentary tract and metabolismblood and blood forming organscardiovascular systemgenito-urinary system and sex hormonesantiinfectives for systemic usemusculo-skeletal systemnervous system and respiratory system; healthcare preparationsnamely food supplements and medical preparations for the treatment of disturbances with and support of digestive enzymesfor optimizing the supply of nutrients to mother and childfor the promotion of fertilityfor the relief and elimination of lactose intolerancefor the development of teethbones and muscles growthfor care during pregnancy and breastfeedingfor supporting the memoryconcentration and learningfor the care of the immune systemfor the strengthening and maintenance of jointscartilagebones and musclesfor the magnesium supply of heartnerves and musclesfor increasing the iron requirementfor increasing the sperm formation and for the folic acid care before and during pregnancy; dietetic preparations for medical purposes in the form of vitaminsmineral nutrientstrace elementsproteins and carbohydrates; food supplements for medical and non-medical purposesnamely for the treatment of disturbances with and support of digestive enzymesfor optimizing the supply of nutrients to mother and childfor the promotion of fertilityfor the relief and elimination of lactose intolerancefor the development of teethbones and muscles growthfor care during pregnancy and breastfeedingfor supporting the memoryconcentration and learningfor the care of the immune systemfor the strengthening and maintenance of jointscartilagebones and musclesfor the magnesium supply of heartnerves and musclesfor increasing the iron requirementfor increasing the sperm formation and for the folic acid care before and during pregnancy
Classe 35
Wholesale and retail store services featuring pharmaceutical and chemical preparations used in industryscienceagriculturehorticulture and forestryespecially for use in the foodstufffood supplementpharmaceutical and cosmetics industriesartificial sweetenerspains and dietsplant extracts and plant oils for cosmetic purposeschemical preparations for pharmaceutical and medical purposesanimal oils and plant oils as well as plant extracts for pharmaceutical and medical purposesproteins for pharmaceutical and medical purposesfood supplements for pharmaceutical and medical purposesminerals and vitamins
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/02/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
18/05/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/02/2021
FIMP
FINAL DISPOSITION PROCESSED
13/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/08/2020
PUBO
PUBLISHED FOR OPPOSITION
18/08/2020
GPNX
NOTIFICATION PROCESSED BY IB
14/08/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/08/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/08/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/07/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/12/2019
GNRT
NON-FINAL ACTION E-MAILED
09/12/2019
CNRT
NON-FINAL ACTION WRITTEN
09/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/11/2019
RFNT
REFUSAL PROCESSED BY IB
31/05/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/05/2019
RFRR
REFUSAL PROCESSED BY MPU
14/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/04/2019
CNRT
NON-FINAL ACTION WRITTEN
18/04/2019
DOCK
ASSIGNED TO EXAMINER
17/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
23/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/03/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DENK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.